Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV Diagnostics: Current Recommendations and Opportunities for Improvement.

Infectious disease clinics of North America·2019
Same author

Direct Diagnostic Tests for Lyme Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2018
Same author

It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study.

PloS one·2018
Same author

Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments.

Annals of emergency medicine·2018
Same author

Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2017
Same author

Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2017
Same journal

HIV seroprevalence, incidence, and viral suppression among Ugandan female bar workers: a population-based study.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Men's preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Preferences for HIV testing among partners of transgender women in Lima, Peru: a discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Trends in sexually transmitted infections by PrEP use among cisgender men who have sex with men in New York City, 2014-2023.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Birth and Infant Growth Outcomes Following Prenatal Exposure to Bictegravir.

Journal of acquired immune deficiency syndromes (1999)·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

The future of HIV testing.

Bernard M Branson1

  • 1Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. bbranson@cdc.gov

Journal of Acquired Immune Deficiency Syndromes (1999)
|March 17, 2011
PubMed
Summary
This summary is machine-generated.

New HIV testing strategies improve early detection of acute and HIV-2 infections. Revised algorithms offer earlier, more accurate identification for effective treatment and prevention efforts.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Traditional HIV testing algorithms face challenges in identifying acute HIV infection and HIV-2.
  • Acute HIV infection poses a high risk of transmission due to viral load.
  • HIV-2 infections may not respond to standard antiretroviral therapies.

Purpose of the Study:

  • To introduce a revised HIV testing algorithm to address limitations of traditional methods.
  • To improve the early and accurate diagnosis of HIV infections, including acute and HIV-2.
  • To enhance HIV treatment initiation and prevention strategies.

Main Methods:

  • Utilizing new Food and Drug Administration-approved diagnostic tools.
  • Implementing immunoassays for earlier antibody detection.
  • Employing HIV RNA tests and combination assays for p24 antigen and antibody screening.

Main Results:

  • New strategies facilitate earlier identification of acute HIV infection.
  • Revised algorithms improve detection of HIV-2 infections.
  • Enhanced diagnostic capabilities lead to more accurate HIV identification.

Conclusions:

  • Revised HIV testing algorithms are crucial for timely treatment and prevention.
  • Earlier diagnosis enables individuals to benefit from effective HIV therapies sooner.
  • Improved diagnostic accuracy strengthens public health efforts in controlling HIV transmission.